Long-term Safety and Tolerability of BHV-7000
for Focal Epilepsy
115 locations incl. Birmingham
Sponsor: Biohaven Therapeutics Ltd.
Sex: All·Age: 18 - 75
Code: NCT06443463·Phase 2·Enrolling By Invitation·Listed Jun 2024
Clinical research site in Burlington, Vermont
As of July 2026, 1 paid clinical trial is recruiting at UVM MC in Burlington, Vermont. Active studies at this site focus on Focal Epilepsy alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in Burlington, VT · Vermont clinical trials